AGIOS PHARMACEUTICALS, INC.·4

Jun 17, 4:15 PM ET

Owen Adams Catherine 4

4 · AGIOS PHARMACEUTICALS, INC. · Filed Jun 17, 2025

Insider Transaction Report

Form 4
Period: 2025-06-13
Transactions
  • Exercise/Conversion

    Common stock

    2025-06-13+1,9773,953 total
  • Exercise/Conversion

    Restricted stock units

    2025-06-131,9771,976 total
    Common stock (1,977 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]The restricted stock units were granted on June 13, 2023. Beginning on June 13, 2024, the shares underlying the stock units will vest in three equal annual installments. Vested shares will be delivered to the reporting person within three business days after such shares become vested.

Documents

1 file
  • 4
    wk-form4_1750191300.xmlPrimary

    FORM 4